Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Retained Earnings (2019 - 2025)

Korro Bio's Retained Earnings history spans 7 years, with the latest figure at -$383.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings fell 143326.12% year-over-year to -$383.8 million, compared with a TTM value of -$383.8 million through Dec 2025, down 143326.12%, and an annual FY2025 reading of -$383.8 million, down 143326.12% over the prior year.
  • Retained Earnings for Q4 2025 was -$383.8 million at Korro Bio, down from -$333.8 million in the prior quarter.
  • The five-year high for Retained Earnings was $574000.0 in Q3 2024, with the low at -$383.8 million in Q4 2025.
  • Average Retained Earnings over 5 years is -$111.1 million, with a median of -$384000.0 recorded in 2022.
  • Year-over-year, Retained Earnings surged 450.0% in 2024 and then plummeted 1503433.33% in 2025.
  • Tracing KRRO's Retained Earnings over 5 years: stood at -$62000.0 in 2021, then plummeted by 164146.77% to -$101.8 million in 2022, then tumbled by 79.71% to -$183.0 million in 2023, then surged by 100.15% to $268000.0 in 2024, then plummeted by 143326.12% to -$383.8 million in 2025.
  • Per Business Quant, the three most recent readings for KRRO's Retained Earnings are -$383.8 million (Q4 2025), -$333.8 million (Q3 2025), and -$315.7 million (Q2 2025).